The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Efficacy of Contralateral Prophylactic Mastectomy in Women With a Personal and Family History of Breast Cancer
Abstract
PURPOSE: To estimate the efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. PATIENTS AND METHODS: We followed the course of 745 women with a first breast cancer and a family history of breast and/or ovarian cancer who underwent contralateral prophylactic mastectomy at the Mayo Clinic between 1960 and 1993. Family history information and cancer follow-up information were obtained from the medical record, a study-specific questionnaire, and telephone follow-up. Life-tables for contralateral breast cancers, which consider age at first breast cancer, current age, and type of family history, were used to calculate the number of breast cancers expected in our cohort had they not had a prophylactic mastectomy. RESULTS: Of the 745 women in our cohort, 388 were premenopausal (age < 50 years) and 357 were post- menopausal. Eight women developed a contralateral breast cancer. Six events were observed among the premenopausal women, compared with 106.2 predicted, resulting in a risk reduction of 94.4% (95% confidence interval [CI], 87.7% to 97.9%). For the 357 postmenopausal women, 50.3 contralateral breast cancers were predicted, whereas only two were observed, representing a 96.0% risk reduction (95% CI, 85.6% to 99.5%). CONCLUSION: The incidence of contralateral breast cancer seems to be reduced significantly after contralateral prophylactic mastectomy in women with a personal and family history of breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Polychemotherapy for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(98)03301-7 · Cited by 2,042
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1
Verhoog, L., Brekelmans, C., Seynaeve, C., van den Bosch, L., Dahmen, G., van Geel, A., Tilanus-Linthorst, M., Bartels, C., Wagner, A., van den Ouweland, A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07065-7 · Cited by 452
BRCA-associated breast cancer in young women.
Robson, M., Gilewski, T., Haas, B., Levin, D., Borgen, P., Rajan, P., Hirschaut, Y., Pressman, P., Rosen, P. P., Lesser, M. L., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1642 · Cited by 302
Fisher, B., Anderson, S., Tan-Chiu, E., Wolmark, N., Wickerham, D. L., Fisher, E. R., Dimitrov, N. V., Atkins, J. N., Abramson, N., Merajver, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.931 · Cited by 272
Peralta, E. A., Ellenhorn, J. D. I., Wagman, L. D., Dagis, A., Andersen, J. S., & Chu, D. Z. J. (2000) · The American Journal of Surgery · doi:10.1016/s0002-9610(00)00505-5 · Cited by 198
Survival in Hereditary Breast Cancer Associated With Germline Mutations of BRCA2
Verhoog, L. C., Brekelmans, C. T. M., Seynaeve, C., Dahmen, G., van Geel, A. N., Bartels, C. C. M., Tilanus-Linthorst, M. M. A., Wagner, A., Devilee, P., Halley, D. J. J., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3396 · Cited by 175
Fisher, E. R., Fisher, B., Sass, R., Wickerham, L., & Collaborating NSABP Investigators (1984) · Cancer · doi:10.1002/1097-0142(19841215)54:12<3002::aid-cncr2820541231>3.0.co;2-v · Cited by 162
Obedian, E., FISCHER, D. B., & Haffty, B. G. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.12.2406 · Cited by 148
The woman at increased risk for breast cancer: evaluation and management strategies
Bilimoria, M. M., & Morrow, M. (1995) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.45.5.263 · Cited by 111
Cited by
Prophylactic mastectomy for the prevention of breast cancer
Lostumbo, L., Carbine, N. E., & Wallace, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002748.pub3 · Cited by 400
van Sprundel, T. C., Schmidt, M. K., Rookus, M. A., Brohet, R., van Asperen, C. J., Rutgers, E. J. T., van‘t Veer, L. J., & Tollenaar, R. A. E. M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602703 · Cited by 291
Herrinton, L. J., Barlow, W. E., Yu, O., Geiger, A. M., Elmore, J. G., Barton, M. B., Harris, E. L., Rolnick, S., Pardee, R., Husson, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.080 · Cited by 268
Risk-reducing mastectomy for the prevention of primary breast cancer
Carbine, N. E., Lostumbo, L., Wallace, J., & Ko, H. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002748.pub4 · Cited by 266
Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer
Evans, D. G. R., Ingham, S. L., Baildam, A., Ross, G. L., Lalloo, F., Buchan, I., & Howell, A. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2583-1 · Cited by 178
Metadata
- Authors
- McDonnell, S. K., Schaid, D. J., Myers, J. L., Grant, C. S., Donohue, J. H., Woods, J. E., Frost, M. H., Johnson, J. L., Sitta, D. L., Slezak, J. M., Crotty, T. B., Jenkins, R. B., Sellers, T. A., & Hartmann, L. C.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-10-01
- Volume
- 19
- Issue
- 19
- Pages
- 3938-3943
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1956689666
- Cited by
- 265
- References
- 13
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of Contralateral Prophylactic Mastectomy in Women With a Personal and Family History of Breast Cancer. https://app.cochat.ai/papers/10.1200/jco.2001.19.19.3938
- The paper
- McDonnell, S. K., Schaid, D. J., Myers, J. L., Grant, C. S., Donohue, J. H., Woods, J. E., Frost, M. H., Johnson, J. L., Sitta, D. L., Slezak, J. M., Crotty, T. B., Jenkins, R. B., Sellers, T. A., & Hartmann, L. C. (2001). Efficacy of Contralateral Prophylactic Mastectomy in Women With a Personal and Family History of Breast Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2001.19.19.3938
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.